Galapagos raises 300 million dollars

Thursday, 13 September 2018 15:34
The biotechnology company Galapagos has raised 300 USD in fresh money from American investors, via the issuing of new shares, it said Thursday.
The Mechelen company issued 2,575,107 new shares, at the price of 116.50 dollars per share.

The Bel 20 company announced Wednesday that its Filgotinib, a drug for rheumatism, has performed well in the phase III study, which facilitates a future commercialization.

The Brussels Times

 
Google Plus

More Stories

Wines and spirits federation wants more breathalyser tests in public places

Wines and spirits federation wants more breathalyser tests in public places

The Belgian Federation of Wines and Spirits, Vinum Et Spiritus, has decided to support the Emile Leus Fund in its efforts to have more alcohol detectors installed in public places.

Belgium, France could need to supply each other with energy this winter

Belgium, France could need to supply each other with energy this winter

The security of France’s electricity supply should be guaranteed this winter, according to the country’s electricity transmission company, RTE, but extra care will need to be taken in January-February and if demand outstrips production, France could need energy from Belgium during those two months.

The year 2018 looks set to be one of Belgium’s driest

The year 2018 looks set to be one of Belgium’s driest

With a month and a half to go before the end of the year, 2018 has had only 118 rainy days, which is within reach of the previous annual record of 143 rainless days, dating back to 2003.